C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
12/2002
12/19/2002	WO2002100327A2 Substituted 1-benzazepines and derivatives thereof
12/19/2002	WO2002085906A3 Phthalazinones derivatives useful as pde4/7 inhibitors
12/19/2002	WO2002083651A3 Pyrimidine compounds as anti-ictogenic and/or anti-epileptogenic agents
12/19/2002	WO2002080161A3 Optical data carrier that contains a merocyanine dye as the light-absorbing compound in the information layer
12/19/2002	WO2002070515A3 Chromane derivatives, process for their preparation and their use as antitumor agents
12/19/2002	WO2002060894A3 Sulfonamide lactam inhibitors of factor xa
12/19/2002	WO2002055501A3 N-pyridyl carboxamide derivatives and pharmaceutical compositions containing them
12/19/2002	WO2002050082A3 Inhibitors of papilloma virus
12/19/2002	US20020193612 Nicotinamide biaryl derivatives useful as inhibitors of PDE4 isozymes
12/19/2002	US20020193604 Aryl borates
12/19/2002	US20020193599 Dihydropyridines and new uses thereof
12/19/2002	US20020193596 Inhibitors of protein isoprenyl transferases
12/19/2002	US20020193590 Tetra- or hexa-hydroazepine compounds substituted at the 4 position with benzofur-7-yl, indol-7-yl, or benzo(b)thiophen-7-yl; antidepressants
12/19/2002	US20020193411 Pesticidal 1-polyarylpyrazoles
12/19/2002	US20020193410 Substituted (aminoiminomethyl or aminomethyl) dihydrobenzofurans and benzopyrans
12/19/2002	US20020193407 Modulators of CCR5 chemokine receptor activity
12/19/2002	US20020193406 Novel compound
12/19/2002	US20020193400 Antidepressant azaheterocyclylmethyl derivatives of 2,3-dihydro-1,4-benzodioxan
12/19/2002	US20020193382 Sulfonamide derivatives, their production and use
12/19/2002	US20020193377 Quinazolines as MMP-13 inhibitors
12/19/2002	US20020193361 For therapy of cancer and other conditions characterized by abnormal cellular proliferation
12/19/2002	DE10128331A1 New 2-(heteroarylsulfonyl-amino)-benzamide derivatives, which are potassium ion channel blocking antiarrhythmic agents, useful for e.g. treating atrial fibrillation or flutter
12/19/2002	DE10121003A1 Anthranilsäureamide, Verfahren zur Herstellung, ihrer Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen Anthranilic acid amides, processes for preparing, their use as a medicament as well as pharmaceutical compositions containing them
12/19/2002	CA2457382A1 Process for the preparation of paroxetine substantially free of alkoxy impurities
12/19/2002	CA2450269A1 Hiv protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis
12/19/2002	CA2450265A1 Hiv protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis
12/19/2002	CA2450262A1 2,5-diarylpyrazines, 2,5-diarylpyridines and 2,5-diarylpyrimidines as crf1 receptor modulators
12/19/2002	CA2448552A1 Modulators of peroxisome proliferator activated receptors (ppar)
12/19/2002	CA2447687A1 Substituted 1-benzazepines and derivatives thereof
12/18/2002	EP1267495A1 RF receiver having cascaded filters and an intermediate amplifier stage
12/18/2002	EP1266897A2 Hypoglycemic imidazoline compounds
12/18/2002	EP1266896A1 Linear ou cyclic ureas, process for their preparation and pharmaceutical compositions containing them
12/18/2002	EP1266887A2 Indenoindoline derivatives, their process of preparation and pharmaceutical compositions containing them
12/18/2002	EP1265890A1 Stereoselective synthesis of nucleoside analogues
12/18/2002	EP1265873A2 4-oxo-1,4-dihydro-3-cinnolinecarboxamides as antiviral agents
12/18/2002	EP1265872A1 4-hydroxycinnoline-3-carboxyamides as antiviral agents
12/18/2002	EP1265863A1 Heterocyclic side chain containing metalloprotease inhibitors
12/18/2002	EP1265862A2 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses
12/18/2002	EP1265853A1 Carboxylic acid derivatives as ip antagonists
12/18/2002	EP1265606A1 Cell adhesion inhibitors
12/18/2002	EP1109619B1 Reactor comprising a contact tube bundle
12/18/2002	EP0930298B1 Fluorinated 1,4-disubstituted piperidine derivatives
12/18/2002	EP0882038B1 substituted n-methyl-n-(4-(piperidin-1-yl)-2-(aryl)butyl)benzamides useful for the treatment of allergic diseases
12/18/2002	CN1096460C Novel substituted N-methyl-N-(4-(piperidin-1-yl)-2-(aryl)butyl)benzamides useful for treatment of allergic diseases
12/18/2002	CN1096450C Process for producing phenoxy propionic acid derivatives
12/17/2002	US6495699 Antiarthritic agents; osteoporosis
12/17/2002	US6495684 Inhibit human factor xa; treating diseases characterized by thrombotic activity; for example 3-((3,5-difluoro-6-(3-(1-methylimidazolin-2-yl)phenoxy)-4-(2,3 -dihydroxypropoxy)pyridin-2-yl)oxy)-4-hydroxybenzamidine
12/17/2002	US6495672 Diagnosis and separation through triplex binding
12/17/2002	US6495576 N-(1-((3,4-dioxo-2-(3-pyridinylamino)-1-cyclobuten-1-yl)amino) -2,2-dimethylpropyl)-4-methylbenzamide for example; treating bladder overactivity, benign prostatic hyperplasia, premature labor, and sexual disorders
12/17/2002	US6495574 Polyhydroxylated monocyclic N-heterocyclic derivatives as anti-coagulants
12/17/2002	US6495571 Administering to the mammal an effective cancer treatment amount of the compound 3,5-dichloro-4,6-diethoxy-2-(trichloromethyl)pyridine or and acid addition salt to treat the cancer
12/17/2002	US6495568 Treatment of tissue ulceration, wound repair and skin diseases
12/17/2002	US6495565 For therapy of acute infection, acute phase response, age related macular degeneration, alcoholism, anorexia, asthma, autoimmune disease, autoimmune hepatitis, bechet's disease, cachexia, calcium pyrophosphate dihydrtate deposition
12/17/2002	US6495562 Such as 6-(2-(4,4-diethyl-1-isopropyl-3,4-dihydro-6-isoquinolinyl)cyclopropyl)-2 -naphthalenecarboximidamide
12/17/2002	US6495561 2-cyclohexyl imidazopyridine NMDA/NR2B antagonists
12/17/2002	US6495550 Substituted benzamido-pyridine derivatives for treatment of disorders mediated by potassium channels
12/17/2002	US6495547 Hampered or impaired relaxation of the fundus to food ingestion; irritable bowel syndrome, anorexia, bloating, early satiety, dyspepsia
12/17/2002	US6495491 Herbicides and insecticides; defoliants, desiccants, haulm killers and especially weed killers
12/17/2002	US6495370 A method for detecting a glutathione-s-transferase isoenzyme in a biological specimen comprising the measurement of glutathione-s-transferase enzymatic activity in the presence and absence an amount of a compound of the formula halo
12/12/2002	WO2002099077A2 Methods and compositions related to tagging of membrane surface proteins
12/12/2002	WO2002098873A1 2-heteroaryl-imidazotriazinones and their use in the treatment of inflammatory or immune diseases
12/12/2002	WO2002098869A2 1,4-disubstituted benzo-fused cycloalkyl urea compounds
12/12/2002	WO2002098865A2 Cyclic nucleotide phosphodiesterase inhibitors, preparation and uses thereof
12/12/2002	WO2002098856A2 Piperazine oxyquinoline (naphthaline) platelet adenosine diphosphate receptor antagonists
12/12/2002	WO2002098854A2 Process for preparing chiral diol sulfones and dihydroxy acid hmg coa reductase inhibitors
12/12/2002	WO2002098425A1 Substituted 4-aryl-3-(3-aryl-1-oxo-2-propenyl)-2(1h)-quinolinones and analogs as activators of caspases and inducers of apoptosis and the use thereof
12/12/2002	WO2002098363A2 NON-PEPTIDE GnRH AGENTS, PHARMACEUTICAL COMPOSITIONS AND METHODS FOR THEIR USES, AND PROCESSES FOR PREPARING THEM
12/12/2002	WO2002076977A3 Rho-kinase inhibitors
12/12/2002	WO2002076976A3 Rho-kinase inhibitors
12/12/2002	WO2002069946A3 Use of triazole compounds for prophylaxis and in therapy for neurodegenerative illnesses, brain traumas and cerebral ischaemia
12/12/2002	WO2002064080A3 Matrix metalloproteinase inhibitors
12/12/2002	WO2002004424A9 Pyrazole derivatives
12/12/2002	WO2001054731A3 Ligand conjugates and methods for preparing same
12/12/2002	US20020188136 Pesticides and herbicides
12/12/2002	US20020188124 Novel spiro compounds
12/12/2002	US20020188122 Such as pyridine-4-carboxaldehyde-(4-Morpholinylprop-3-yl) imine for use in therapy as cytokine inhibitors
12/12/2002	US20020188018 3-indolyl-4-phenyl-1H-pyrrole-2,5-dione derivatives as inhibitors of glycogen synthase kinase-3beta
12/12/2002	US20020188006 4-hydroxypiperidine derivatives having antiarrhythmic activity
12/12/2002	US20020188004 Heterocycle carboxamides as antiviral agents
12/12/2002	US20020187992 Prodrugs via acylation with cinnamate
12/12/2002	US20020187991 Barbituric acid derivatives
12/12/2002	US20020187976 New benzofurane derivatives, their preparation process, their use as medicaments and the pharmaceutical compositions containing them
12/12/2002	DE10125961A1 Carbazolderivate und deren Verwendung zur Herstellung einer Arzneimittelzusammensetzung zur Behandlung von im Zusammenhang mit NPY stehenden Leiden Carbazole derivatives and their use for the preparation of a pharmaceutical composition for the treatment of related ailments associated with NPY
12/12/2002	CA2449843A1 Non-peptide gnrh agents, pharmaceutical compositions and methods for their use, and processes for preparing them
12/12/2002	CA2449813A1 Process for preparing chiral diol sulfones and dihydroxy acid hmg coa reductase inhibitors
12/12/2002	CA2449109A1 2-heteroaryl-imidazotriazinones and their use in the treatment of inflammatory or immune diseases
12/12/2002	CA2446696A1 Cyclic nucleotide phosphodiesterase inhibitors, preparation and uses thereof
12/11/2002	WO2001083471A1 Novel indole derivatives exhibiting chymase-inhibitory activities and process for preparation thereof
12/11/2002	EP1264829A1 Oxygen-containing heterocyclic compounds
12/11/2002	EP1264827A1 Process for the preparation of Tosylbenzylformamides
12/11/2002	EP1264820A1 Novel amide compounds
12/11/2002	EP1264597A2 Methods and compositions for treating cancer
12/11/2002	EP1263756A2 Beta-amino acid derivatives as inhibitors of matrix metalloproteases and tnf-alpha
12/11/2002	EP1263755A2 Cyclic beta-amino acid derivatives as inhibitors of matrix metalloproteases and tnf-alpha
12/11/2002	EP1263753A1 Imidazol derivatives as raf kinase inhibitors
12/11/2002	EP1263732A1 Corticotropin releasing factor antagonists
12/11/2002	EP1263731A1 Method for producing 5-aryl nicotinaldehydes
12/11/2002	EP1263729A1 Azacyclic compounds for use in the treatment of serotonin related diseases
12/11/2002	EP1263727A1 2-oxo-1-pyrrolidine derivatives, process for preparing them and their uses
12/11/2002	EP1263720A1 Azetidine derivatives, preparation thereof and pharmaceutical compositions containing same

1 ... 411 412 413 414 415 416 417 418 419 420 421 422 423 424 425 426 427 428 429 430 431 ... 694